Researchers Submit Patent Application, "Cereblon Ligands and Uses Thereof", for Approval (USPTO 20240059711).

MLA

“Researchers Submit Patent Application, ‘Cereblon Ligands and Uses Thereof’, for Approval (USPTO 20240059711).” Pharma Business Week, Mar. 2024, p. 4334. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=175910596&authtype=sso&custid=ns315887.

APA

Researchers Submit Patent Application, “Cereblon Ligands and Uses Thereof”, for Approval (USPTO 20240059711). (2024). Pharma Business Week, 4334.

Chicago

“Researchers Submit Patent Application, ‘Cereblon Ligands and Uses Thereof’, for Approval (USPTO 20240059711).” 2024. Pharma Business Week, March, 4334. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=175910596&authtype=sso&custid=ns315887.